Recruiting Tomorrow’s Medtech Workforce: Insights from Ireland
Cultivating fresh thinking and continual adaptation is key.
Tag Archives: Medtronic
Coming Soon: Medtronic-IBM Watson App to Empower Diabetes Patients
Announced at CES 2016, the cognitive app will leverage predictive analytics to help patients better manage their condition.
Most Popular Stories of 2015
A review of the articles you found most interesting this year.
Medtronic Takes Manufacturing to Galway
The company will invest €13 million in the facility, which will make drug-coated balloons for peripheral artery disease.
Big Data Meets Diabetes
Meaningful data integration and patient empowerment are driving next-generation diabetes technology.
Medtronic’s European Research Center Focuses on Innovation for Survival
The company’s Bakken Research Centre in the Netherlands is centrally located for technology development and collaboration with physicians.
The United States of America v. Medtronic., a corporation, and S. Omar Ishrak and Thomas M. Teft, individuals
There is no such thing as minimum or maximum compliance—there is just compliance.
FDA Files Consent Decree Against Medtronic and CEO Omar Ishrak
Medtronic repeatedly fails to correct manufacturing violations related to its Synchromed II Implantable Infusion Pump Systems.
Medtronic repeatedly fails to correct manufacturing violations related to its Synchromed II Implantable Infusion Pump Systems.
Medtronic and IBM Partner to Transform Diabetes Management
IBM’s Watson Health Unit is forming several collaborations to facilitate personalized health on a massive scale.
IBM’s Watson Health Unit is forming several collaborations to facilitate personalized health on a massive scale.
Medtronic Posts Higher-Than-Expected Q3 Profits
The company’s heart devices such as implantable defibrillators, artificial valves and devices to treat atrial fibrillation, contributed to a 5 percent increase in sales in the cardiac and vascular business, its largest unit.
The company’s heart devices such as implantable defibrillators, artificial valves and devices to treat atrial fibrillation, contributed to a 5 percent increase in sales in the cardiac and vascular business, its largest unit.
